Listed by the USPTO as LYNCH, ROBERT A
Tech Center 3700 • Art Units: 3731 3771 3773
This examiner grants 80% of resolved cases
LYNCH, ROBERT A is assigned to tech center 3700 and art unit 3731. The profile includes 883 resolved cases and an 80.3% allowance rate. The median time to allowance is 1071 days. Interviews correspond to a 12.9% lift in the allowance outcome.
The substantial case volume supports a clear recorded allowance pattern. Allowance is common, while the interview association is positive but limited, suggesting that written claim analysis and prosecution preparation may have greater practical importance than interview activity alone. The leading companies are Edwards Lifesciences Corporation, Boston Scientific Corporation, and Intuitive Surgical Operations Inc.
The leading firms are FOLEY & LARDNER LLP, SEAGER, TUFTE & WICKHEM, LLP, and ARRIGO, LEE, GUTTMAN & MOUTA-BELLUM, LLP. They identify the main representation relationships.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19070997 | SYSTEMS AND METHODS FOR TREATING ANEURYSMS | Non-Final OA | Covidien LP |
| 19028834 | DEVICES FOR APPROXIMATING TISSUE AND RELATED METHODS OF USE | Non-Final OA | Boston Scientific Scimed, Inc. |
| 19028637 | ENDOSCOPIC NEEDLE ASSEMBLY | Final Rejection | BOSTON SCIENTIFIC SCIMED, INC. |
| 18953927 | ENDOSCOPIC NEEDLE ASSEMBLY | Non-Final OA | BOSTON SCIENTIFIC SCIMED, INC. |
| 19410331 | APPARATUS AND METHOD FOR MINIMALLY INVASIVE SUTURING | Final Rejection | INTUITIVE SURGICAL OPERATIONS, INC. |
| 19016565 | APPARATUS AND METHOD FOR MINIMALLY INVASIVE SUTURING | Non-Final OA | INTUITIVE SURGICAL OPERATIONS, INC. |
| 18998629 | TISSUE CLOSURE DEVICE AND TISSUE CLOSING METHOD | Non-Final OA | Cilag GmbH International |
| 18966797 | TIBIAL TRAY INSERTER | Non-Final OA | GLOBUS MEDICAL, INC. |
| 19209692 | FUNCTIONAL INDICATORS FOR ROBOTIC MEDICAL SYSTEMS | Non-Final OA | Auris Health, Inc. |
| 19095774 | SPRING AND COIL DEVICES FOR PAPILLARY MUSCLE APPROXIMATION AND VENTRICLE REMODELING | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 19079303 | SYSTEMS OF HEART VALVE DELIVERY | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 19044668 | UNIDIRECTIONAL VALVULAR IMPLANT | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18411286 | EXPANDABLE SHEATH | Final Rejection | EDWARDS LIFESCIENCES CORPORATION |
| 18950308 | MEDICAL DEVICE ANCHORING APPARATUS AND PLACEMENT TOOL | Final Rejection | MEDTRONIC, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy80.3% of resolved applications examined by Robert A Lynch were allowed (883 resolved cases), compared with 63.1% across Art Unit 3731 over the last five years.
This examiner's interview lift is +12.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Robert A Lynch took 1,071 days on average from filing to allowance.
Robert A Lynch examines applications in Art Unit 3731 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
